chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started feeling sick on the 14th - tickle in my throat and feeling rundown. And the next day, headache and my head felt cloudy and I was congested. I thought I had a head cold. The next day, I was sweating so profusely - my shirt was wet and I couldn't stop sweating but went from sweating to freezing and back and forth. I did not have a fever. I had awful body aches. It hurt standing up - joints hurt. Not normal for me. The headache and body aches continued and I was nauseous and I had diarrhea. By Sunday, I felt okay. I was alright. I was still really tired but I wasn't like I was like I was the week prior. By Monday, I was doing pretty good and then Tuesday, I had a pre-op appt. I had to get tested before the operation and they tested it and it was positive. I had to cancel my surgery. 10 day quarantine from the 20th. I've been symptom free during quarantine. I just used OTC - ibuprofen and took a sinus medication: a Tylenol, cold and sinus OTC to help during the time of they symptoms. I did contact my primary care doctor on the 20th when I had the positive test because I had seen her on the 12th. So it was remote - email visit.
Left arm was red and swollen. Pt went to hospital for evaluation and treatment. Was given KEFLEX 500mg #28 1 QID.
This initial spontaneous report was received from Licensed Practical Nurse (LPN) via a field employee and refers to a female patient who was 9 or 10 years old. No information was provided regarding medical history, concurrent conditions or concomitant medications. On an unspecified date, the patient was vaccinated with GARDASIL 9. Specifics about the dose, lot # and administration schedule were unknown, but the LPN did state that the patient received at least one dose of GARDASIL 9. In approximately 2016 (reported as about a year ago), the patient developed an unspecified adverse reaction after receiving GARDASIL 9. She saw a physician for the event. The outcome of the adverse event was unknown. The LPN did not provide causality assessment. The mother of the patient requested clinic medical records and planned to speak with a lawyer. Additional information has been requested.
patient received covid -19 vaccine at 1552 . patient stood and went with guardian to registration desk to schedule second dose appointment. shortly after mother and registration clerk called out for help. patient c/o dizziness and pale. mother assisting pt to floor and supporting her.  patient assisted to chair. still responsive answering questions. reports not eating at all that day. pt provided with juice and snack. assisted to bed and observed for 30 mins.
Pt. in observation was feeling dizzy and hot flash.  Paramedics assessed pt. once symptoms subsided and vitals were cleared pt. was released to leave.  (tent 11).
t105 w/jerking & shaking 1 day p/vax; No LOC & vomiting; have sent for ER visit notes; hx by mom report;
Positive covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive covid-19) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced COVID-19 (Positive covid-19). At the time of the report, COVID-19 (Positive covid-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Apr-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant details were provided No treatment details were provided
In the past, always got reaction from all Pfizer Covid shots she has had/ With every single one of them, was sick for a few days; The initial case was missing the following minimum criteria: unspecified event. Upon receipt of follow-up information on 21Sep2023, this case now contains all required information to be considered valid.  This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID: (004756). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "recovered", described as "In the past, always got reaction from all Pfizer Covid shots she has had/ With every single one of them, was sick for a few days". Additional information: Patient was calling about Comirnaty 2023-2024 formula for 12 years and up (Lot number: HG4629). She was concerned whether she got valid dose of vaccine because, she did not have reaction. She was wondering whether she was given prefilled syringe, with no medication in it. In the past, she always got reaction from all Pfizer Covid shots she has had. With every single one of them, she was sick for a few days. This time, she had no reaction at all.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Within 3 hours of injection of Flu vaccine began experiencing symptoms of flu. Symptoms progressed until I actually all flu effects including cold chills, fever, loss of appetite, aches, weakness, for 3 days.
Erythema (L) arm, c/o pain (L) arm tender. *Indurated has gotten sick with vaccine before achey coughing c/o headaches. Total body pain.
experienced hives; Initial information received on 03-Nov-2020 regarding an unsolicited valid non-serious case from a physician.  This case involves a 8 years old patient of unknown gender who experienced hives (urticaria), while being treated with vaccine influenza quadrival a-b vaccine [Fluzone Quadrivalent].  The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications were not reported.  On an unknown date, the patient received a dose of suspect influenza quadrival a-b vaccine [lot number: unknown and expiration date: unknown] at an unknown dose and frequency via unknown route and unknown site for prophylactic vaccination.  On an unknown date (unknown latency), after starting the suspect vaccine therapy, the patient experienced hives (urticaria).  No laboratory data was not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.
I had my vaccination on 09/12/2022. I had a seizure on 01/12/2023. I was diagnosed on 01/13/2023 with a brain tumor Gliosarcoma that they believed that that was 6 months in advance to 08/2022. I currently am followed by Oncology Neurology and Radiation for ongoing treatment.
12/18/2020: ER visit showing Patient Chief complaint of Left lower leg pain; plt count 243x10^3 WNL;  Given Clindamycin 600mg IV in the ER and discharged on Bactrim 800mg PO for Acute Cellulitis diagnosis.   1/2021: Follow-up at PCP office showed plt wnl on routine labs. Resolution of leg symptoms per patient.  3/15/21 & 4/15/21: Received Moderna vaccine one & two at Public health clinic    (Additional Information for Item 12: Cigarette smoker 10.5 Pack years, hypertension)   Additional information for Item 18: 4/19/2021-4/27/21: Presented to Medical Center ER with complaints of Left leg redness and weakness. Stated he felt weak and tired after receiving the second dose and has been feeling worse since. His friend brought him to the ER stating "he didn't seem like himself." Admitted for acute cellulitis of Left lower extremity, altered mental status, and started on IV Vancomycin (4/19/21-4/22/21) and Levaquin (4/19/21-4/26/21). Baseline plt 74 at admission. Rivaroxaban 10mg PO QD was given 4/19/21 until 4/21/21. Plt count continued to downtrend during admission. Hematology/Oncology service consulted on 4/22/21 who initially suggested thrombocytopenia possibly due to infection or DIC. Yet, worsening thrombocytopenia despite improvement of infection and clinical status was noted. The etiology was then suggested to be Vancomycin induced thrombocytopenia, so Vancomycin was stopped on 4/22/21. Platelet count  Patient was discharged with p.o. prednisone and p.o. Levaquin on 4/27/21. Patient stated almost full resolution of LLE pain and redness. Plt count upon discharge was 51. Instructed to stop Rivaroxaban.  5/1/21:Patient presented to ER at Medical Center for Leg pain. US Doppler was negative and patient given Clindamycin IV 600mg in the ER and discharged with Bactrim 800mg qd to be continued until his PCP appointment.   May 5, 2021: PCP placed patient on Clindamycin for recurrent cellulitis.   5/14/21-5/22/21: Patient presented to Medical Center ER with worsening left leg cellulitis. Patient was afebrile with a normal wbc count. Upon admission, Plt count was 36. Patient was started on Linezolid 600mg q12h and Ceftriaxone qd. Antibiotics were changed later to Tefalo 600mg Q12Hto be started on 5/15/21. ID consult recommended Daptomycin given patient's thrombocytopenia. Patient was continued on Daptomycin throughout admission and upon discharge, patient's leg was almost back to baseline. Plt count was 138. To rule out other causes of thrombocytopenia, patient medications were reviewed and imaging was done in addition to labs drawn during this admission. See above for the labs. All alternative causes during this admission were ruled out.
This spontaneous report was received from a physician refers to a patient of unknown age and gender. On 29-JUL-2015, the patient was vaccinated with improperly stored PROQUAD (Merck) lot # K025766, expiry date 08-JUN-2015. This is one of the several reports received from the same reporter. Additional information has been requested.
8 doses given today after vial was punctured 30May2021. Technician did not know vial was from 30May2021".; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (8 doses given today after vial was punctured 30May2021. Technician did not know vial was from 30May2021".) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (8 doses given today after vial was punctured 30May2021. Technician did not know vial was from 30May2021".). On 01-Jun-2021, EXPIRED PRODUCT ADMINISTERED (8 doses given today after vial was punctured 30May2021. Technician did not know vial was from 30May2021".) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    Concomitant medication was not provided.  Treatment information was not provided.
Abnormal/heavy menstrual bleeding; Abnormal/heavy menstrual bleeding; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 50-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Batch/Lot Number: EW0161, Expiry date not reported) via an unspecified route of administration in arm left on 23Apr2021 11:15 (at the age of 50-year-old) as a single dose for COVID-19 immunisation at pharmacy or drug store. The patient medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication(s) included bupropion hydrochloride (WELLBUTRIN) taken for an unspecified indication, start and stop date were not reported within 2 weeks of vaccination. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Batch/Lot number: ER8737, Expiry date not reported), via an unspecified route of administration in arm left on 02Apr2021 11:30 (at the age of 50-year-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 28May2021 10:00, the patient experienced abnormal/heavy menstrual bleeding. The patient was in perimenopausal and have not had a cycle in over 6 months. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. Outcome of the events was not resolved. Device Date was reported as 01Jun2021.  Follow-Up (30Jun2021): Follow-up attempts are completed. No further information is expected.
Large raised red rash at injection site appeared on 3/26/2021 (received vaccine on 3/18/2021). Weakness in arm. Slight pain, slight itching.
The patient described throat tightness and mild shortness of breath. Vital signs were normal (including O2 sat of 99%). Although the symptoms improved over the course of 35 minutes, they did not resolve, so she was taken to the local ED for additional monitoring.
Within 24 hours, as expected: fever  of 99.3, overall body aches,  head ache, sore arm at injection site (bruised feeling), incapacitated, lasted a day.    4 days later I have an unexpected 4" wide warm to the touch red rash around the injection site--oddly not at the site of the former bandage covering the injection (which was removed the same day after the shot was administered). No blisters.
No adverse reaction; Got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Got vaccinated after BUD) and NO ADVERSE EVENT (No adverse reaction) in an 83-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse reaction). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Got vaccinated after BUD) and NO ADVERSE EVENT (No adverse reaction) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse reaction) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Got vaccinated after BUD).    No concomitant medications were reported.  It was reported that, the patient received vaccine after the beyond use-by date.  No treatment medications were reported.
No adverse effects reported; vaccine that was administer was over the Beyond Use Date of 3/3/2023.
Evening of 3/5/07 began experiencing nausea, light headedness and body aches. 3/6/07 awoke with sore throat and right anterior adenopathy. Temp 98.7
19AUG98 c/o feet hurt to walk, on runny nose, whelpy rash;20AUg98 went to MD;had whelpy rash over body not onhands, feet or face;prescribed an antihistimine clariten;temp x 2 days 101;swollen feet & swollen joints & stiffness;
1. Adverse Events resulting from injection: Bursitis, Torn Rotator Cuff injury, Torn Labrum, Shoulder impingement. These injuries required surgical intervention which took place on 9/22/2022. I am still recovering and have Physical Therapy 3x/week.
pt contacted our office March 2020, stating she had nerve pain from flu vaccination. Pt stated injection was administered 2 finger breaths below acromion process almost level to armpit. Pt stated no pain during injection, then 1-2 days later started feeling sharp pain, stated having difficulty with mobility. Pt first sought medical attention from urgent care Feb 6, 2020, then went to primary care provider Dec 27th 2019, was prescribed medication for nerve pain.
Patient felt itchy throat (discomfort at a 4 out of 10 scale) and difficulty breathing (discomfort at a 5 out of 10 scale) with 5 minutes of being vaccinated. Vaccine administering pharmacist gave Patient a 25 mg Benadryl tablet , which provided no relief 10 minutes later. Pharmacist then injected .3 MG Epinephrine shot in Patient's left quadricep which provided instant relief for about 30 minutes.  Patient then proceeded to the ER where he was given a 20 MG  Pepcid tablet, Two 20 MG Prednisone tablets and discharged a few hours later with the instructions to: take One 25 mg Benadryl tablet every 6 hours as needed; One 20 MG  Pepcid tablet twice a day and  Two 20 MG Prednisone tablets for Five days with a follow up visit to Patient's allergist.
Given vaccine 4/20/2021. 4/21/2021 patient became fatigued and had some chills. He also complained of a tenderness under his jaw.
sustained injury; This is a spontaneous report received from Pfizer sponsored program.  A contactable consumer (patient) reported a female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications was not reported. The patient experienced sustained injury after first dose for unknown reason and seeking to reschedule appointment for second dose of vaccine on 14apr2021due to injury on an unspecified date. The outcome of event was unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
was having issues with seasonal allergies; not feeling well after getting shots; flu symptoms last week due to the flu shot; Initial information received on 13-Oct-2023 regarding an unsolicited valid non-serious courtesy case received from a consumer/non-hcp.  This case involves a 50-years-old female patient (48 kg) who was not feeling well after getting shots, had flu symptoms last week due to the flu shot and was having issues with seasonal allergies after receiving tetanus toxoid and influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing Pulmonary arterial hypertension.  Concomitant medications included sulfamethoxazole, trimethoprim (Bactrim); Furosemide; Ondansetron; Sulfamethoxazole, Trimethoprim; Spironolactone; salbutamol sulfate (Proair); Oxygen; Ambrisentan; sildenafil citrate (Sildenafil); Fluconazole; Mycophenolate Mofetil; paracetamol (Tylenol); diphenhydramine hydrochloride (Benadryl); pantoprazole sodium sesquihydrate (Pantoprazole Sodium); and treprostinil sodium (Remodulin) for Product used for unknown indication.  On 14-Sep-2023, the patient received unknown dose of suspects influenza vaccine produced by unknown manufacturer and tetanus toxoid produced by unknown manufacturer (strength, formulation, batch number, expiry date unknown) via unknown route in unknown administration site for Influenza immunization and Tetanus immunization respectively.  On 17-Sep-2023 the patient had not feeling well after getting shots (malaise) (latency: 3 days) following the administration of influenza vaccine and tetanus toxoid.  On an unknown date in Sep-2023 the patient had flu symptoms last week due to the flu shot (influenza) (unknown latency) following the administration of influenza vaccine and (tetanus toxoid.  On an unknown date in 2023 the patient was having issues with seasonal allergies (seasonal allergy) (unknown latency) following the administration of influenza vaccine and tetanus toxoid.  Relevant laboratory test results included: Smear cervix - on an unknown date in September 2023: [result unknown]  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the events (not feeling well after getting shots, flu symptoms last week due to the flu shot, was having issues with seasonal allergies).  At time of reporting, the outcome was Unknown for all the events.
Patient for her first shingle vaccine on 08/27/2022. She called the pharmacy today 08/28/22 reporting that she has a hard time breathing and also body aches. She can barely move and have to seat down/ lay down on her chair. She also reported having fever but does not know the exact temperature. Patient reported did not take any fever reducing medication because she was told not to take the by her doctor due to her health condition. Patient is advised to get to the ER or call Urgent care immediately since she reported trouble breathing.
Temp, body aches, chills, headache, dizzy, (L) arm very painful, swollen
Chills, headache, chest pain for 45 minutes. Gone now. 4/29-contacted the patient. Patient feels much better. No chest pain now; some chills; going back to work.
Woke with bilateral conjunctivitis and scleral erythema.  Burning of both eyes. No vision impairment but a lot of tearing. No treatment needed and resolved in 48 hrs.
pt recv vax 27JUL98 930AM & mom states 630PM pt suffered apparent sz or fainting spell;family MD said 2nd immun should not have been given together;neurologist stated inj could be given together;they were given in different arms;
Initial report was received 13 September 2011 from a consumer, who is also the patient. A male patient (age not reported) had received a first dose of ACAM2000 (lot number VV04-003A) in the left arm, and a first dose of TYPHIM VI, lot number G1124-1, and a first dose of Anthrax vaccine (other manufacturer, lot number SAV288) on 09 September 2011. The patient had previously received an injection of FLUZONE, lot number UH453AB on 14 August 2011. On 13 September 2011, four days after receiving ACAM2000, TYPHIM VI and Anthrax vaccines, the patient experienced very mild chest pressure and he found "two spots"; one behind both ears between the ear and the hairline. The patient was advised to be evaluated by their physician on 13 September 2011. Relevant laboratory and diagnostic test data was unknown at the time of the report. Past medical history, concomitant medications and concurrent illnesses were not reported. Outcome was unknown. Documents held by sender: None.
Woke up at 1:00am with chills and uncontrollable shaking.  Took Tylenol PM and fell back to sleep.  Woke up at 5:30am with headache and full body muscle aches.  1:00 pm took Advil and felt much better an hour afterwards.
Pt initally with HA and lethargy.  School nurse reports she looked gray "like she needed oxygen".  Then 2-4 hours later she developed dytonic reactions with back arching and mucscle spasms that resolved with IV benadryl.  She was admitted to Medical Center at 3am on 11/5/2009.  She did well until 3:30pm when she again began having muscle twitching which is lessening after IV benadryl.  With the parents permission I video taped these movements.  Of note, the school nurse reports a large percentage of student (estimated >25%) had c/o HA and lethargy after their H1N1 immunization. 11/9 and 11/12/2009 hospital records for 11/4-11/6/2009.Dc Dx dystonia ICD-9 code 333.72    Patient with c/o's dizziness, tremors. Tx: IV Benadryl. Neuro exam was normal, neuro consult indicated that MD found no neurological basis for patient's c/o's. 11/19 and 11/25/09:  Hospital records and neurology consultation received for dates of service 11/4-11/6/09:  Dx:  dystonia vs. chorea vs. conversion reaction. Assessment:  Neurology consult and examination find no chorea, athetosis, dystonic reaction or akathisia.  MRI normal.  There is no LOC with events.  Dr. suggests converstion type reaction.  Treated with Benadryl IV while inpatient.
G40.901 STATUS EPILEPTICUS 6/9/2021 STATUS EPILEPTICUS J96.00 ACUTE RESPIRATORY FAILURE 6/9/2021 STATUS EPILEPTICUS
Patient was given Varivax right deltoid on 09/28/2005. On 10/03/2005 he developed a zoster like rash of left shoulder and left lateral neck with typical lesions itch and small vesicles. Vaccine given sub cutaneous deltoid area.
Pfizer vaccine 12+ administered to an 11 year old patient no adverse reactions were noted.